| [1] | Zhang, Z.Y., Harischandra, D.S., Wang, R., et al. (2023). TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease. Science 381: eadd6696. DOI: 10.1126/science.add6696. |
| [2] | Jena, K.K., Kolapalli, S.P., Mehto, S., et al. (2018). TRIM16 controls turnover of protein aggregates by modulating NRF2, ubiquitin system, and autophagy: Implication for tumorigenesis. Mol. Cell Oncol. 5: e1532251. DOI: 10.1080/23723556.2018.1532251. |
| [3] | Chen, L., Zhu, G., Johns, E.M., et al. (2018). TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. Nat. Commun. 9: 1223. DOI: 10.1038/s41467-018-03499-z. |
| [4] | Zhu, G., Harischandra, D.S., Ghaisas, S., et al. (2020). TRIM11 prevents and reverses protein aggregation and rescues a mouse model of Parkinson's disease. Cell Rep. 33: 108418. DOI: 10.1016/j.celrep.2020.108418. |
| [5] | Chen, L., Brewer, M.D., Guo, L., et al. (2017). Enhanced degradation of misfolded proteins promotes tumorigenesis. Cell Rep. 18: 3143−3154. DOI: 10.1016/j.celrep.2017.03.010. |
| Xu Y., Kwok H., and Chen L. (2024). TRIM11: A powerful guardian of proteostasis. The Innovation Life 2(1): 100048. https://doi.org/10.59717/j.xinn-life.2024.100048 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
The dual role of TRIM11 in cancer and neurodegenerative diseases.